The first reaction of many patients after being diagnosed with breast cancer is "save their lives first, not breast-conserving", "breast-conserving treatment is easy to relapse, and breast-conserving resection is cleaner and more thorough", "breast-conserving may have the possibility of recurrence, and it is better to remove it". In fact, this concept is wrong. Patients with breast-conserving and radiotherapy can get a higher survival rate than patients with mastectomy. A literature analysis in Cancer, one of the most authoritative journals in oncology, shows that breast-conserving therapy is still a promising and effective treatment compared with mastectomy. This study comes at a good time, because in the past 10 years, more and more breast cancer patients have chosen mastectomy, even for patients with early breast cancer. Some patients, such as young and wealthy breast cancer patients, always assume that the survival probability of mastectomy is greater than that of local excision. , followed up until 2009. They studied the relationship between treatment methods and survival rate in different age groups and different tumor types. The results showed that the survival rate of early breast cancer women who received local excision plus radiotherapy was higher than that of patients who received mastectomy. In fact, for patients of any age and tumor type, the survival rate of local lesion resection plus radiotherapy is better than that of mastectomy. Hormone-sensitive breast cancer patients over 50 years old benefit the most from breast-conserving treatment. The researchers observed that during the follow-up period, the death risk of breast cancer was 65,438+04% lower than that of patients undergoing mastectomy under similar clinical conditions-that is, breast-conserving treatment reduced the death risk by 65,438+04%. The reason and mechanism of breast-conserving therapy superior to mastectomy have not been deeply discussed by researchers. The treatment choices patients need to make are related to whether their condition recurs or not. I think when patients know that the survival rate after breast-conserving surgery for early breast cancer is higher, their choices will undoubtedly be affected. The breast-conserving treatment mentioned here is not a simple breast-conserving treatment, but a "breast-conserving operation" with a more elaborate and complicated standard process than mastectomy. It is necessary to carry out a standardized breast-conserving operation process in a large comprehensive breast center with specialized breast imaging department, breast surgery department, breast disease department and breast internal medicine department, rather than a simple operation that is cut casually. The whole operation process needs the surgeon's careful design, careful dissection and patient waiting. For early breast cancer, breast-conserving surgery and sentinel lymph node biopsy can achieve the same therapeutic effect as mastectomy and avoid many postoperative complications, which is the best treatment recommended by our professional doctors.